Panacea Life Sciences Holdings, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $540.00K.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was -$159.36K.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $400.48K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-03-31 | $540.00K 10-Q · filed 2023-05-12 | $540.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$159.36K 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | |
| 2022-03-31 | -$159.36K 10-Q · filed 2023-05-12 | |
| 2021-03-31 | $443.39K 10-Q/A · filed 2021-05-27 | |
| 2018-12-31 | $400.48K 10-K · filed 2019-03-29 |